Kindstar Globalgene Technology, Inc. (9960) Stock Statistics & Valuation Metrics

Kindstar Globalgene Technology, Inc. has a market cap or net worth of HK$1.45B. The enterprise value is HK$174.01M.

Kindstar Globalgene Technology, Inc. has 1,040,923,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Kindstar Globalgene Technology, Inc.’s return on equity (ROE) is -0.02 and return on invested capital (ROIC) is -1.52%.

The current PE Ratio of Kindstar Globalgene Technology, Inc. is ―. Kindstar Globalgene Technology, Inc.’s PEG ratio is 0.08.

In the last 12 months, Kindstar Globalgene Technology, Inc. had revenue of 927.57M and earned -54.59M in profits. Earnings per share was -0.06.

In the last 12 months, operating cash flow was -7.64M and capital expenditures -61.62M, giving a free cash flow of -69.26M billion.

Kindstar Globalgene Technology, Inc. pays an annual dividend of HK$0.024, resulting in a dividend yield of 1.74%

Kindstar Globalgene Technology, Inc. upcoming earnings date is Apr 1, 2026, TBA (Confirmed).

Kindstar Globalgene Technology, Inc. as a current ratio of 2.63, with Debt / Equity ratio of 16.85%

In the past 12 months, Kindstar Globalgene Technology, Inc. has paid 4.49M in taxes.

Kindstar Globalgene Technology, Inc. EV to EBITDA ratio is -9.09, with an EV/FCF ratio of -5.93.

Kindstar Globalgene Technology, Inc. has HK$1.61B in cash and marketable securities with HK$471.06M in debt, giving a net cash position of HK$1.14B billion.

Gross margin is 45.03%, with operating margin of -4.88%, and net profit margin of -5.89%.

The average price target for Kindstar Globalgene Technology, Inc. is HK$1.50, which is 11.43% higher than the current price. The consensus rating is Hold